SculptCare is not a compounding pharmacy and does not engage in pharmaceutical compounding as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act
[10] [11] NICE recommends Mounjaro for adults with type 2 diabetes when: It is used according to the recommendations for GLP-1 receptor agonists in NICE guideline NG28 on type 2 diabetes in adults The person has a BMI of at least 35 kg/m (adjusted to 32.5 kg/m for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean family backgrounds) and specific psychological or medical problems associated with obesity, or The person has a BMI lower than 35 kg/m (adjusted as above), and insulin treatment would have significant occupational implications, or weight loss would benefit other significant obesity-related comorbidities In line with NG28, treatment should only be continued if there is a beneficial metabolic response (a reduction of at least 11 mmol/mol [1.0%] in HbA1c and weight loss of at least 3% of initial body weight after 6 months)
Understanding gauge numbers Gauge measures needle thickness
At this dose, the full range of tirzepatide's effects is typically apparent
People taking tirzepatide were less likely to experience heart attacks and similar problems compared to others, including people on older GLP-1s, the studies found
